Copper/topa quinone-containing histamine oxidase from Arthrobacter globiformis. Molecular cloning and sequencing, overproduction of precursor enzyme, and generation of topa quinone cofactor. 1995

Y H Choi, and R Matsuzaki, and T Fukui, and E Shimizu, and T Yorifuji, and H Sato, and Y Ozaki, and K Tanizawa
Institute of Scientific and Industrial Research, Osaka University, Japan.

The gene coding for histamine oxidase has been cloned and sequenced from a Coryneform bacterium Arthrobacter globiformis. The deduced amino acid sequence consists of 684 residues with a calculated molecular mass of 75,109 daltons and shows a high overall identity (58%) with that of phenethylamine oxidase derived from the same bacterial strain. Although the sequence similarities are rather low when compared with copper amine oxidases from other organisms, the consensus Asn-Tyr-Asp/Glu sequence, in which the middle Tyr is the precursor to the quinone cofactor (the quinone of 2,4,5-trihydroxyphenylalanine, topa) covalently bound to this class of enzymes, is also conserved in the histamine oxidase sequence. To identify the quinone cofactor, an overexpression plasmid has been constructed for the recombinant histamine oxidase. The inactive enzyme purified from the transformed Escherichia coli cells grown in a copper-depleted medium gained maximal activity upon stoichiometric binding of cupric ions. Concomitantly with the enzyme activation by copper, a brownish pink compound was generated in the enzyme, which was identified as the quinone of topa by absorption and resonance Raman spectroscopies of the p-nitrophenylhydrazine-derivatized enzyme and found at the position corresponding to the precursor Tyr (Tyr-402). Therefore, the copper-dependent autoxidation of a specific tyrosyl residue operates on the formation of the topa quinone cofactor in this enzyme, as recently demonstrated with the precursor form of phenethylamine oxidase (Matsuzaki, R., Fukui, T., Sato, H., Ozaki, Y., and Tanizawa, K. (1994) FEBS Lett. 351, 360-364).

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010659 Phenylhydrazines Diazo derivatives of aniline, used as a reagent for sugars, ketones, and aldehydes. (Dorland, 28th ed)
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D003300 Copper A heavy metal trace element with the atomic symbol Cu, atomic number 29, and atomic weight 63.55. Copper-63,Copper 63
D004269 DNA, Bacterial Deoxyribonucleic acid that makes up the genetic material of bacteria. Bacterial DNA
D004295 Dihydroxyphenylalanine A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific. Dopa,3,4-Dihydroxyphenylalanine,3-Hydroxy-DL-tyrosine,Dihydroxyphenylalanine Hydrochloride, (2:1),beta-Hydroxytyrosine,3 Hydroxy DL tyrosine,3,4 Dihydroxyphenylalanine,beta Hydroxytyrosine
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D004792 Enzyme Precursors Physiologically inactive substances that can be converted to active enzymes. Enzyme Precursor,Proenzyme,Proenzymes,Zymogen,Zymogens,Precursor, Enzyme,Precursors, Enzyme
D006631 Amine Oxidase (Copper-Containing) A group of enzymes including those oxidizing primary monoamines, diamines, and histamine. They are copper proteins, and, as their action depends on a carbonyl group, they are sensitive to inhibition by semicarbazide. Diamine Oxidase,Histaminase,Amine Oxidase, Copper-Containing,Copper Amine Oxidase,Diaminobenzidine Oxidase,Semicarbazide-Sensitive Amine Oxidase,Xylylene Diamine Oxidase,Amine Oxidase, Copper,Amine Oxidase, Copper Containing,Amine Oxidase, Semicarbazide-Sensitive,Copper-Containing Amine Oxidase,Diamine Oxidase, Xylylene,Oxidase, Copper Amine,Oxidase, Copper-Containing Amine,Oxidase, Diamine,Oxidase, Diaminobenzidine,Oxidase, Semicarbazide-Sensitive Amine,Oxidase, Xylylene Diamine,Semicarbazide Sensitive Amine Oxidase
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein

Related Publications

Y H Choi, and R Matsuzaki, and T Fukui, and E Shimizu, and T Yorifuji, and H Sato, and Y Ozaki, and K Tanizawa
November 1996, Gene,
Y H Choi, and R Matsuzaki, and T Fukui, and E Shimizu, and T Yorifuji, and H Sato, and Y Ozaki, and K Tanizawa
March 1994, Biochemical and biophysical research communications,
Y H Choi, and R Matsuzaki, and T Fukui, and E Shimizu, and T Yorifuji, and H Sato, and Y Ozaki, and K Tanizawa
September 1993, Journal of bacteriology,
Y H Choi, and R Matsuzaki, and T Fukui, and E Shimizu, and T Yorifuji, and H Sato, and Y Ozaki, and K Tanizawa
September 2007, Journal of the American Chemical Society,
Y H Choi, and R Matsuzaki, and T Fukui, and E Shimizu, and T Yorifuji, and H Sato, and Y Ozaki, and K Tanizawa
January 1995, Methods in enzymology,
Y H Choi, and R Matsuzaki, and T Fukui, and E Shimizu, and T Yorifuji, and H Sato, and Y Ozaki, and K Tanizawa
March 2004, Biochemistry,
Y H Choi, and R Matsuzaki, and T Fukui, and E Shimizu, and T Yorifuji, and H Sato, and Y Ozaki, and K Tanizawa
July 1993, Biochimica et biophysica acta,
Y H Choi, and R Matsuzaki, and T Fukui, and E Shimizu, and T Yorifuji, and H Sato, and Y Ozaki, and K Tanizawa
July 2008, Acta crystallographica. Section F, Structural biology and crystallization communications,
Y H Choi, and R Matsuzaki, and T Fukui, and E Shimizu, and T Yorifuji, and H Sato, and Y Ozaki, and K Tanizawa
March 2003, Biochimica et biophysica acta,
Y H Choi, and R Matsuzaki, and T Fukui, and E Shimizu, and T Yorifuji, and H Sato, and Y Ozaki, and K Tanizawa
June 2003, Biochemistry,
Copied contents to your clipboard!